A 21-year-old woman presents with complaints of easy bruising, bleeding gums, heavy periods, and nosebleeds. What is her diagnosis?
Findings from a retrospective chart review showed a need to carefully monitor inflammatory biomarkers and anticoagulant dosage in patients with severe COVID-19.
Researchers attempted to develop a predictive model for the risk of postpartum hemorrhage in patients who have ITP.
Researchers sought to determine what should be the primary treatment goal for patients with sickle cell disease.
Researchers sought to determine whether idecabtagene vicleucel, a CAR-T cell therapy, would be a viable treatment option in heavily pretreated patients with relapsed or refractory multiple myeloma.
Certain hemoglobin variants and conditions have been shown to affect red blood cell lifespan and hence may lead to false HbA1c results.
Although the mortality of patients with high-risk pulmonary embolism has decreased over time, the decrease cannot be attributed to improved treatments for pulmonary embolism.
Nonpharmacologic treatment with cognitive-behavioral therapy combined with physiotherapy may be an effective pain management strategy for patients with severe hemophilia.
Patients with kidney failure who receive a kidney transplant, including those with sickle cell disease, have lower mortality.
Researchers assessed the effect of COVID-19 convalescent plasma on survival benefit at 7 and 14 days for patients hospitalized with the disease.
Investigators determined whether ABO and Rh blood groups were associated with risk for SARS-CoV-2 infection and severe COVID-19 illness.
Prophylactic anticoagulation is associated with reduced risk of 30-day mortality among patients admitted to hospital with COVID-19.
January 2021 FDA approvals of import to physician assistants and nurse practitioners include treatments for HIV, heart failure, dry eye disease, and light chain amyloidosis.
A 21-year-old woman presents with a complaint of continued iron deficiency despite treatment with oral iron supplementation.
A team of investigators evaluated clinical characteristics, hemostasis management, and clinical outcomes of bleeding events in women and girls with hemophilia.
For patients with sickle cell disease, HSCT may not be associated with a significant increase in CKD incidence or prevalence following transplantation.
For patients with iron deficiency anemia, oral iron supplementation use alone is comparable to oral supplementation with vitamin C.
Higher doses of blood thinners are potentially harmful and have no clear benefits for hospitalized COVID-19 patients.
The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.
Prothrombotic autoantibodies, similar to those with antiphospholipid syndrome, appear to be elevated in hospitalized patients with COVID-19.